Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroidectomy | 4 | 2021 | 31 | 1.120 |
Why?
|
| Calcitriol | 1 | 2021 | 25 | 0.710 |
Why?
|
| Hypocalcemia | 1 | 2021 | 19 | 0.710 |
Why?
|
| Postoperative Complications | 3 | 2021 | 1292 | 0.570 |
Why?
|
| Calcium | 1 | 2021 | 573 | 0.550 |
Why?
|
| Mass Screening | 2 | 2013 | 690 | 0.550 |
Why?
|
| Bariatric Surgery | 2 | 2017 | 59 | 0.520 |
Why?
|
| Preoperative Care | 2 | 2018 | 190 | 0.510 |
Why?
|
| Obesity, Morbid | 2 | 2013 | 97 | 0.460 |
Why?
|
| Gastroplasty | 1 | 2013 | 16 | 0.410 |
Why?
|
| Arthroplasty, Replacement | 1 | 2013 | 16 | 0.400 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2013 | 28 | 0.400 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 55 | 0.380 |
Why?
|
| Lower Extremity | 1 | 2013 | 164 | 0.360 |
Why?
|
| Patient Selection | 3 | 2018 | 482 | 0.290 |
Why?
|
| Thyroid Neoplasms | 2 | 2008 | 74 | 0.280 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2004 | 9 | 0.220 |
Why?
|
| Lymph Node Excision | 1 | 2004 | 43 | 0.220 |
Why?
|
| Middle Aged | 9 | 2021 | 17407 | 0.180 |
Why?
|
| Tonsillectomy | 1 | 2021 | 11 | 0.180 |
Why?
|
| Parotid Gland | 1 | 2021 | 11 | 0.180 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 168 | 0.160 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2018 | 71 | 0.160 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 161 | 0.160 |
Why?
|
| Parathyroid Neoplasms | 1 | 2018 | 5 | 0.150 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2018 | 6 | 0.150 |
Why?
|
| Radionuclide Imaging | 1 | 2018 | 122 | 0.150 |
Why?
|
| Adenoma | 1 | 2018 | 68 | 0.140 |
Why?
|
| Male | 9 | 2021 | 29591 | 0.140 |
Why?
|
| Hernia, Hiatal | 1 | 2017 | 26 | 0.140 |
Why?
|
| Spirometry | 1 | 2017 | 111 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 708 | 0.130 |
Why?
|
| Female | 8 | 2021 | 32585 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 147 | 0.130 |
Why?
|
| Hypoxia | 1 | 2017 | 113 | 0.130 |
Why?
|
| Lung Diseases | 1 | 2017 | 176 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 532 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 432 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2021 | 3260 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2021 | 6568 | 0.100 |
Why?
|
| Humans | 11 | 2021 | 62925 | 0.100 |
Why?
|
| Musculoskeletal Diseases | 1 | 2013 | 103 | 0.100 |
Why?
|
| Postoperative Care | 2 | 2017 | 122 | 0.100 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 186 | 0.090 |
Why?
|
| Adult | 5 | 2018 | 16669 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2013 | 863 | 0.080 |
Why?
|
| Laparoscopy | 2 | 2017 | 472 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1541 | 0.070 |
Why?
|
| Gastric Bypass | 1 | 2006 | 76 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2013 | 2054 | 0.060 |
Why?
|
| Pancreatectomy | 1 | 2006 | 101 | 0.060 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2006 | 111 | 0.060 |
Why?
|
| Iodine Radioisotopes | 1 | 2004 | 53 | 0.060 |
Why?
|
| Neck | 1 | 2004 | 46 | 0.050 |
Why?
|
| Prognosis | 2 | 2006 | 1733 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 340 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2004 | 579 | 0.050 |
Why?
|
| Age Factors | 1 | 2004 | 1558 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 14286 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 1594 | 0.040 |
Why?
|
| Parathyroidectomy | 1 | 2018 | 7 | 0.040 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2018 | 33 | 0.040 |
Why?
|
| Obesity | 1 | 2006 | 1231 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 5421 | 0.040 |
Why?
|
| Herniorrhaphy | 1 | 2017 | 70 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2006 | 5601 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 290 | 0.030 |
Why?
|
| Oxygen | 1 | 2017 | 316 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 1141 | 0.030 |
Why?
|
| Massachusetts | 1 | 2021 | 2061 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2553 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1115 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2448 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 3752 | 0.020 |
Why?
|
| Thyroid Nodule | 1 | 2008 | 14 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2008 | 82 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4650 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 490 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2006 | 58 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 337 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2006 | 191 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 728 | 0.010 |
Why?
|